Berry Global reported Q3 2024 results, achieving net sales of $3.2 billion and operating income of $303 million. The company saw a 2% increase in overall organic volumes, with growth across all four operating segments. Adjusted EPS was $2.18, up 16% year-over-year, and operating EBITDA reached $546 million. The company is progressing with its portfolio optimization, including the planned spin/merger of its Health, Hygiene & Specialties segment.
Net sales reached $3.2 billion with a 2% decrease due to lower resin prices, offset by volume growth.
Operating income increased by 13% to $303 million, driven by organic volume growth and positive price-cost spread.
Adjusted EPS was $2.18, reflecting a 16% increase compared to the previous year.
Organic volume growth of 2% was achieved, with all four operating segments contributing.
Berry Global provided fiscal year 2024 guidance, including adjusted earnings per share of $7.60 and free cash flow between $800 and $900 million. The company is committed to achieving a leverage ratio at or below 3.5x.
Visualization of income flow from segment revenue to net income